Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Drugmakers and pharmacists battle over who gets to make obesity drugs
NPR
Wed, 11/20/24 - 11:21 am
Tags:
Novo Nordisk, Eli Lilly, obesity, weight loss, GLP-1 agonists, compounded drugs
Novo’s Wegovy Launched in China at a Fraction of US Price
BioSpace
Mon, 11/18/24 - 11:28 am
Tags:
Novo Nordisk, Wegovy, Cina, weight loss, GLP-1 agonists
Survey Finds Most GLP-1 Users Discontinue Drug Before Reaching Goal Weight
Xtalks
Fri, 11/15/24 - 11:27 am
Tags:
Omada Health, GLP-1 agonists, obesity, weight loss, Novo Nordisk, Eli Lilly, Ozempic, Zepbound, Mounjaro, Wegovy
Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO
Beckers Hospital Review
Thu, 11/7/24 - 11:14 am
Tags:
Novo Nordisk, Ozempic, semaglutide, compounded drugs
FDA adds aspiration warning to Ozempic, Mounjaro and other GLP-1 labels
Beckers Hospital Review
Wed, 11/6/24 - 08:01 pm
Tags:
FDA, warnings, aspiration, Ozempic, Wegovy, Saxenda, Mounjaro, Novo Nordisk, Eli Lilly
Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail
Fierce Biotech
Wed, 11/6/24 - 08:00 pm
Tags:
Novo Nordisk, kidney disease, clinical trials, ocedurenon
Novo Nordisk Q3 earnings: Wegovy sales soar 79% year-over-year
Yahoo Finance
Wed, 11/6/24 - 11:44 am
Tags:
Novo Nordisk, Wegovy, earnings
States slow to cover GLP-1s for weight loss
Axios
Wed, 11/6/24 - 11:37 am
Tags:
Medicaid, GLP-1 agonists, Novo Nordisk, Eli Lilly, Wegovy, Zepbound
Wegovy reduces all-cause admissions: 3 study findings
Beckers Hospital Review
Mon, 11/4/24 - 11:19 am
Tags:
Novo Nordisk, Wegovy, hospital admissions, clinical trials
Novo pens $285M biobucks deal to use Ascendis' tech to create monthly GLP-1 agonist
Fierce Biotech
Mon, 11/4/24 - 11:13 am
Tags:
Novo Nordisk, Ascendis Pharma, biobucks, drug development
Novo, with new results, to seek approval for obesity drug in MASH
BioPharma Dive
Fri, 11/1/24 - 11:25 am
Tags:
Novo Nordisk, semaglutide, MASH
Novo takes big step toward ending Ozempic, Wegovy shortages
BioPharma Dive
Wed, 10/30/24 - 08:48 pm
Tags:
Novo Nordisk, drug shortages, obesity, Ozempic, Wegovy
Backlash builds against Novo’s Catalent takeover
Pharma Voice
Wed, 10/30/24 - 11:40 am
Tags:
Novo Holdings, Novo Nordisk, Catalent, M&A, Roche
Weight-loss drugs didn't curb health costs within two years
Reuters
Thu, 10/24/24 - 11:11 am
Tags:
Novo Nordisk, Eli Lilly, Wegovy, Zepbound, obesity
Lilly to launch its obesity drug in Denmark, Novo Nordisk's home market
Reuters
Thu, 10/24/24 - 09:53 am
Tags:
Eli Lilly, Mounjaro, Novo Nordisk, Denmark, obesity
Novo Nordisk's oral diabetes drug cuts heart-related risks by 14% in study
Reuters
Mon, 10/21/24 - 09:39 am
Tags:
Novo Nordisk, Rybelsus, cardiovascular events
FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage
Pharma Voice
Mon, 10/21/24 - 09:37 am
Tags:
FDA, GLP-1 agonists, Ozempic, Wegovy, Novo Nordisk, drug shortages, Eli Lilly, Zepbound
Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in phase 2
Fierce Biotech
Wed, 10/16/24 - 12:17 pm
Tags:
Gan & Lee, GLP-1, Novo Nordisk, Ozempic, type 2 diabetes
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
BioPharma Dive
Fri, 10/11/24 - 11:10 am
Tags:
Novo Nordisk, Eli Lilly, obesity, Zebound, Wegovy, CagriSema, Amgen, MariTide, oforglipron, Veru, enobosarm, nimacimab, Skye Bioscience
Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
Reuters
Fri, 10/11/24 - 09:42 am
Tags:
Novo Nordisk, artificial intelligence, India, R&D

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.